Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07259941

PET-CT in Lymphoma Among the Eldery

PET-CT Imaging Findings and Metabolic Parameters in Elderly Patients With Lymphoma

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
63 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers

Summary

This study investigates PET-CT imaging patterns and metabolic parameters in elderly patients (≥60 years) diagnosed with lymphoma, aiming to enhance diagnostic accuracy and prognosis using 18F-FDG PET/CT scans.

Detailed description

This cross-sectional study involves both retrospective and prospective data collection from elderly lymphoma patients (aged 60 years or older) at the Nuclear Medicine Unit, South Egypt Cancer Institute. It evaluates the PET-CT imaging findings alongside metabolic parameters such as Standardized Uptake Value (SUV), Metabolic Tumor Volume (MTV), and Total Lesion Glycolysis (TLG). The study addresses diagnostic challenges in elderly patients due to atypical presentations and comorbidities and fills the gap of scarce local data in Egypt. Imaging analysis includes visual and semiquantitative assessment of lymphatic and extranodal lesions post-injection of 18F-FDG, assessing tumor metabolic activity to provide prognostic insights. Data analysis uses SPSS with relevant statistical tests to validate findings.

Conditions

Timeline

Start date
2026-01-01
Primary completion
2027-01-01
Completion
2027-02-01
First posted
2025-12-02
Last updated
2025-12-02

Source: ClinicalTrials.gov record NCT07259941. Inclusion in this directory is not an endorsement.

PET-CT in Lymphoma Among the Eldery (NCT07259941) · Clinical Trials Directory